Spectrum News: UC-backed startup hopes to save lives with AI
Genexia aims to detect heart disease in women by using mammograms
By combining existing mammograms with its artificial intelligence, a University of Cincinnati-backed startup hopes to detect heart disease and save lives, Spectrum News reported.
Genexia, founded by Kelly Cohen, Dino Martis and Anoop Sathyan, aims to use explainable AI in mammograms for early detection of coronary artery disease to significantly reduce deaths and quality of life degradation for women.
Cardiovascular disease is the No. 1 killer of women in the United States and worldwide. In the U.S. alone, 500,000 women die annually as a result of heart disease.
“Women are not as fortunate. the symptoms are not that observable as with a man," said Cohen, who survived a heart attack. "I hope that our technology would make the difference and provide women with the chance I was provided."
The technology wouldn’t require any additional tests.
“By attaching this diagnostic to the mammogram, which they conveniently and regularly engage with, we are now able to proactively identify coronary artery disease for women who previously would have been not diagnosed,” Martis said.
Featured image at top: A woman receives a mammogram. Photo/Rhoda Baer, National Cancer Institute via Unsplash
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.